Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Edesa Biotech, Inc. logo — Clinical stage treatments for inflammatory and immune-relate...

Edesa Biotech, Inc.

Clinical stage treatments for inflammatory and immune-related diseases (Nasdaq: EDSA)

Founded 2015 Canada Markham, Canada 20 employees Grant Total: $53.00M Biotechnology, Life Sciences

General Information

Company Name Edesa Biotech, Inc.
Founded Year 2015
Location Canada Markham, Canada
Employees 20
Industries Biotechnology, Life Sciences
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Edesa Biotech, Inc.. To contact Edesa Biotech, Inc., visit edesabiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Edesa Biotech, Inc. compare?

A PDF of Edesa Biotech, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Edesa Biotech, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Edesa Biotech, Inc.

Edesa Biotech is a biotechnology startup that was founded in 2015. The company operates in the biotechnology industry and has recently received a significant $10.00M post-IPO debt investment on 12 October 2023, led by Par Nijhawan. As a venture capital analyst, it's important to note that Edesa Biotech has demonstrated its potential for growth and innovation in the biotechnology sector with this recent funding influx. This investment is indicative of the confidence that Par Nijhawan and other investors have in the company's vision and capabilities. With this substantial capital injection, Edesa Biotech has the financial resources to further develop its biotechnology offerings and potentially expand its operations. This could position the company for significant growth and impact in the biotechnology industry.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $10.00M 1
Par Nijhawan
12 Oct 2023
Grant $23.00M 1
Government of Canada
Government of Canada
12 Oct 2023
Post IPO Equity $10.00M -
22 Mar 2022
Post IPO Equity $10.00M -
25 Feb 2021

FAQ About Edesa Biotech, Inc.

Clinical stage treatments for inflammatory and immune-related diseases (Nasdaq: EDSA)
Edesa Biotech, Inc. was founded in 2015.
Edesa Biotech, Inc. is headquartered in Markham, Canada.
Edesa Biotech, Inc. operates in Biotechnology and Life Sciences.
Edesa Biotech, Inc. has approximately 20 employees.
Edesa Biotech, Inc. has completed 4 funding rounds, raising a total of $53.00M. The latest funding stage is Grant.

We're actively collecting intelligence on Edesa Biotech, Inc..

Source: BounceWatch company record for Edesa Biotech, Inc., https://bouncewatch.com/company/edesa-biotech, updated 30 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes